Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Cavia porcellus | Histamine H1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | lamin | 0.0033 | 0.1919 | 0.0928 |
Trypanosoma cruzi | cytosolic leucyl aminopeptidase, putative | 0.0063 | 0.5251 | 0.5 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0025 | 0.1095 | 0.0985 |
Onchocerca volvulus | 0.0033 | 0.1919 | 1 | |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0025 | 0.1095 | 0.1097 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.1919 | 0.1865 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.1919 | 0.1865 |
Echinococcus multilocularis | lamin | 0.0033 | 0.1919 | 0.1865 |
Schistosoma mansoni | lamin | 0.0033 | 0.1919 | 0.0928 |
Echinococcus granulosus | leucine aminopeptidase protein | 0.0106 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0025 | 0.1095 | 0.0985 |
Echinococcus multilocularis | musashi | 0.0033 | 0.1919 | 0.1865 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0066 | 0.0066 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0025 | 0.1095 | 0.1036 |
Echinococcus granulosus | leukotriene A 4 hydrolase | 0.0106 | 0.9976 | 0.9976 |
Mycobacterium ulcerans | leucyl aminopeptidase | 0.0106 | 1 | 0.5 |
Toxoplasma gondii | leucyl aminopeptidase LAP | 0.0106 | 1 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0017 | 0.0256 | 0.0256 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0025 | 0.1095 | 0.1036 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0025 | 0.1095 | 0.1036 |
Mycobacterium leprae | Probable cytosol aminopeptidase PepB | 0.0106 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.1919 | 0.1923 |
Loa Loa (eye worm) | brahma associated protein | 0.0025 | 0.1095 | 0.1097 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.1919 | 0.1923 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0025 | 0.1095 | 0.1036 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.1919 | 0.1865 |
Mycobacterium tuberculosis | Probable aminopeptidase PepB | 0.0106 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1853 | 0.1858 |
Onchocerca volvulus | 0.0033 | 0.1919 | 1 | |
Plasmodium falciparum | M17 leucyl aminopeptidase | 0.0063 | 0.5251 | 1 |
Echinococcus multilocularis | leucine aminopeptidase protein | 0.0106 | 1 | 1 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0106 | 0.9976 | 0.9976 |
Plasmodium vivax | M17 leucyl aminopeptidase, putative | 0.0106 | 1 | 1 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.1919 | 0.1953 |
Trypanosoma brucei | metallo-peptidase, Clan MF, Family M17 | 0.0063 | 0.5251 | 0.5 |
Echinococcus granulosus | lamin | 0.0033 | 0.1919 | 0.1865 |
Brugia malayi | hypothetical protein | 0.0095 | 0.8771 | 1 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.1919 | 0.0928 |
Wolbachia endosymbiont of Brugia malayi | leucyl aminopeptidase | 0.0106 | 1 | 0.5 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0025 | 0.1095 | 0.1036 |
Trypanosoma cruzi | metallo-peptidase, Clan MF, Family M17, putative | 0.0063 | 0.5251 | 0.5 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0106 | 0.9976 | 1 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0025 | 0.1095 | 0.1036 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0106 | 0.9976 | 1 |
Leishmania major | cytosolic leucyl aminopeptidase,metallo-peptidase, Clan MF, Family M17 | 0.0063 | 0.5251 | 0.5 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.1919 | 0.1923 |
Brugia malayi | brahma associated protein 60 kDa | 0.0025 | 0.1095 | 0.0985 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.1919 | 0.1953 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0025 | 0.1095 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 0.021 mg kg-1 | The compound was tested in vivo for inhibitory effect on 48-h homologous passive cutaneous anaphylaxis(PCA) in rats administered peroally | ChEMBL. | 1350797 |
ID50 (functional) | = 0.0041 mg kg-1 | The compound was tested in vivo for the inhibition of IgG1-mediated bronchoconstriction in guinea pig at 0.03 mg/kg administered peroally | ChEMBL. | 1350797 |
Inhibition (binding) | = -1 % | Binding affinity for Muscarinic acetylcholine receptor M1 from rat striatum, using [3H]-quinuclidinyl benzilate as radioligand at 10 uM. | ChEMBL. | 1350797 |
Inhibition (binding) | = -1 % | Binding affinity for Muscarinic acetylcholine receptor M1 from rat striatum, using [3H]-quinuclidinyl benzilate as radioligand at 10 uM. | ChEMBL. | 1350797 |
Ki (binding) | = 5.2 nM | Binding affinity for histamine H1 receptor from guinea pig cerebellum, using [3H]-pyrilamine as radioligand at 0.1 microM. | ChEMBL. | 1350797 |
Ki (binding) | = 5.2 nM | Binding affinity for histamine H1 receptor from guinea pig cerebellum, using [3H]-pyrilamine as radioligand at 0.1 microM. | ChEMBL. | 1350797 |
Potency (functional) | = 0.0056 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.